(Q79327416)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

5

Samir S Taneja

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Iman Osman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Jie Dai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Maryann Mikhail

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Daniel Navarro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Peng Lee

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Paul Christos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Ruoqian Shen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

David M Nanus

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

2628-2636

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Expression and immunolocalisation of neutral endopeptidase in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Neutral endopeptidase protein expression and prognosis in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Identification and characterization of two androgen response regions in the human neutral endopeptidase gene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Synergy in tumor suppression by direct interaction of Neutral Endopeptidase with PTEN

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Involvement of neutral endopeptidase in neoplastic progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with caucasian prostate cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Racial Disparity of Epidermal Growth Factor Receptor Expression in Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

PTEN expression in melanoma: relationship with patient survival, Bcl-2 expression, and proliferation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Pten dose dictates cancer progression in the prostate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

The pattern of CD10 expression in selected pathologic entities of the prostate gland

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Antibody-based profiling of the phosphoinositide 3-kinase pathway in clinical prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

The biology and clinical relevance of the PTEN tumor suppressor pathway

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Akt-regulated pathways in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

PTEN: life as a tumor suppressor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Cell lines used in prostate cancer research: a compendium of old and new lines--part 1.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22312

7 January 2021

Identifiers

DOI

10.1002/CNCR.22312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17083125%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference